Noncoronary Thrombolysis References:

[Sherry S.  Thrombolytic therapy for noncoronary
diseases.  Ann Emerg Med 1991;20(4):396-404.]
Good Review.

[Goldhaber SZ, Markis JE, Meyerovitz MF, et al.  Acute
pulmonary embolism treated with tissue plasminogen activator.
Lancet 1986; Oct. 18:886-889.]

[Verstraete M, Miller GAH, Bounameaux H, et al. Intravenous and
intrapulmonary recombinant tissue-type plasminogen activator in
the treatment of actue massive pulmonary embolism.  Circulation
1988;77(2):353-360.]

[Goldhaber SZ, Meyerovitz MF, Markis JE, et al.  Thrombolytic
therapy of acute pulmonary embolism: current status and future
potential.  J Am Coll Cardiol 1987 10(5):96B-104B.]

[Elliot MS, Immelman EJ, Jeffery P, et al.  A comparitive
randomized trial of heparin versus streptokinase in the
treatment of acute proximal venous thrombosis: an interim
report of a prospective trial.  Br J Surg 1979;66:838-843.]
Shows that thrombolysis decreases long-term sequelae, which
heparin does not.

[Arnesen H, Heilo A, Jakobsen E, Ly B, Skaga E.  A prospective
study of streptokinase and heparin in the treatment of deep vein
thrombosis.  Acta Med Scand 1978;203:457-463.]

[Rogers LQ, Lutcher CL.  Streptokinase therapy for deep vein
thrombosis: a comprehensive review of the English literature.
Am J Med 1990;888:389-395.]